Severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood lymphocytes (PBLs) followed by immunization with these MUC1-expressing rBCG strains developed specific protective immunity against MUC1-positive human breast cancer xenografts. The gene discussed is MUC1; the disease is breast cancer.